Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis C × Introns × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 6 Neuroendocrine Tumors 2 Multiple Myeloma 2 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Cirrhosis 1 Hepatitis C 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Hepatocellular 1

Interventions

telaprevir 1 peginterferon alfa-2a 1 hepatitis C immune globulin, human 1 elbasvir-grazoprevir drug combination 1 Ribavirin 1 Introns 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00273247 2006-01-09

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

National Cancer Institute, Milan

Phase 3 Completed

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡